Skip to main content
. 2021 Aug 3;12:4408. doi: 10.1038/s41467-021-24627-2

Fig. 1. NanoVelcro Chips for detecting single and clustered circulating trophoblasts (cTBs) in placenta accreta spectrum (PAS) disorder.

Fig. 1

a Abnormal invasion and adherence of placental trophoblasts into the uterine myometrium, classified into placenta accreta, increta, and percreta based on the severity of the disorder. During implantation and placentation, a small number of cTBs sheds from the placenta into the maternal circulation. NanoVelcro Chip, composed of an overlaid polydimethylsiloxane (PDMS) chaotic mixer and an anti-EpCAM-coated silicon nanowire substrates (SiNWS), was adopted to capture both single and clustered cTBs (colored in green) in maternal blood, allowing for noninvasive detection of PAS disorder. The trophoblast origin of the cTBs was confirmed by detecting trophoblast-specific genes and immunocytochemistry (ICC) staining on the captured cTBs. b Representative micrographs of ICC staining on a single cTB and clustered cTBs (DAPI+/CK7+/HLA-G+/CD45–) captured by NanoVelcro Chips. Blue: DAPI stained nuclei; green: FITC stained CK7; orange: TRITC stained HLA-G; red: CY5 stained CD45. Scale bar, 10 µm. Data are representatives of five independent assays.